Pavlik harness and Frejka pillow: compliance affects results of outpatient treatment

Michal Zídka1,2, Valér Džupa3

  • 1Department of Orthopaedics, CLPA-Mediterra, Sokolovská 304, 190 61, Prague 9, Czech Republic. michal.zidka@mediterra.cz.

Insights

This study found that both the Frejka pillow and Pavlik harness are equally effective for treating infant hip dysplasia. Parental compliance, however, was better with the Frejka pillow, highlighting the importance of parental involvement in treatment decisions.

Area of Science:

  • Pediatric Orthopedics
  • Developmental Biology

Background:

  • Outpatient treatment of hip dysplasia in newborns yields excellent results.
  • General screening combined with early treatment using functional abduction devices is effective.
  • The Frejka pillow and Pavlik harness are common treatment devices in many regions.

Purpose of the Study:

  • To compare the efficiency and duration of treatment for hip dysplasia using the Frejka pillow versus the Pavlik harness.
  • To determine if the choice of abduction device influences parental compliance with the treatment protocol.

Main Methods:

  • Analysis of data from 286 infants diagnosed with hip dysplasia in early life via clinical and sonographic screening.
  • Treatment device selection (Frejka pillow for 145 infants, Pavlik harness for 137) was based on clinical findings, sonographic severity (Graf classification), and parental cooperation.
  • Documentation of treatment duration and follow-up loss rates for each device.

Main Results:

  • Overall outpatient treatment success rate was 98.6%.
  • No significant difference in treatment duration or efficiency between the Frejka pillow and Pavlik harness for comparable pathologies.
  • Statistically significant greater parental non-compliance observed with the Pavlik harness (p=0.0279, OR=2.7).

Conclusions:

  • Both Frejka pillow and Pavlik harness demonstrate comparable treatment efficiency for infant hip dysplasia.
  • Parental cooperation is a critical factor in successful screening and treatment.
  • Informed parental consent and consideration of comfort during nursing care are essential for treatment compliance.
Abstract

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.0K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
854
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
974
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.9K
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
756